Obesity and metabolic comorbidities: Environmental diseases?

Oxidative Medicine and Cellular Longevity

Volumn , Issue , 2013, Pages

  Lubrano, Carla ^a   Genovesi, Giuseppe ^a   Specchia, Palma ^a   Costantini, Daniela ^a   Mariani, Stefania ^a   Petrangeli, Elisa ^a,b   Lenzi, Andrea ^a   Gnessi, Lucio ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE HEALTH EFFECTS; CHEMICAL EXPOSURE; ENDOCRINE DISRUPTING COMPOUND; ENDOCRINE FUNCTIONS; HAZARDOUS CHEMICALS; METABOLIC SYSTEMS; POTENTIAL HEALTH; SYNTHETIC CHEMICALS;

CHEMICALS; DETOXIFICATION; METABOLISM; NUTRITION; RISK ASSESSMENT;

CHEMICAL CONTAMINATION;

4,4' ISOPROPYLIDENEDIPHENOL; ANTIOXIDANT; AROMATIC HYDROCARBON RECEPTOR; ATRAZINE; BIOLOGICAL MARKER; CHEMICAL COMPOUND; CHLORPHENOTANE; CHLORPYRIFOS; CONSTITUTIVE ANDROSTANE RECEPTOR; DIETHYLSTILBESTROL; DIOXIN; ENDOCRINE DISRUPTOR; FLAME RETARDANT; GLUCOSE; HERBACEOUS AGENT; INSULIN; METHOXYCHLOR; NONYLPHENOL; PERFLUOROOCTANESULFONIC ACID; PERFLUOROOCTANOIC ACID; PHTHALIC ACID; PHTHALIC ACID DIBUTYL ESTER; PLASTICIZER; POLYBROMINATED DIPHENYL ETHER; POLYCHLORINATED BIPHENYL DERIVATIVE; PREGNANE X RECEPTOR; STEROID; TRICLOSAN; UNINDEXED DRUG; VINCLOZOLIN;

ADIPOCYTE; ADIPOSE TISSUE; CELL DIFFERENTIATION; CHEMICAL COMPOSITION; COMORBIDITY; CONTAMINATION; DETOXIFICATION; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; EPIGENETICS; GENE EXPRESSION; HERBAL MEDICINE; HUMAN; LABORATORY TEST; LOW DRUG DOSE; METABOLIC DISORDER; NONHUMAN; OBESITY; OXIDATIVE STRESS; REVIEW; RISK ASSESSMENT; RISK FACTOR; METABOLISM; MITOCHONDRION; POLLUTANT;

ENDOCRINE DISRUPTORS; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL POLLUTANTS; HUMANS; MITOCHONDRIA; OBESITY; OXIDATIVE STRESS;

EID: 84876563551     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2013/640673     Document Type: Review

References (124)

1. http://ec.europa.eu/health/nutrition-physical-activity/docs/ implementation-report-en.pdf
2. Klimentidis Y. C., Beasley T. M., Lin H. Y., Murati G., Glass G. E., Guyton M., Newton W., Jorgensen M., Heymsfield S. B., Kemnitz J., Fairbanks L., Allison D. B., Canaries in the coal mine: a cross-species analysis of the plurality of obesity epidemics. Proceedings of the Royal Society B 2011 278 1712 1626 1632 2-s2.0-79955378057 10.1098/rspb.2010.1890
3. Donini L. M., Cuzzolaro M., Spera G., Badiali M., Basso N., Bollea M. R., Bosello O., Brunani A., Busetto L., Cairella G., Cannella C., Capodaglio P., Carbonelli M. G., Castellaneta E., Castra R., Clini E., Contaldo F., Dalla Ragione L., Dalle Grave R., D'Andrea F., Del Balzo V., De Cristofaro P., Di Flaviano E., Fassino S., Ferro A. M., Forestieri P., Franzoni E., Gentile M. G., Giustini A., Jacoangeli F., Lubrano C., Lucchin L., Manara F., Marangi G., Marcelli M., Marchesini G., Marri G., Marrocco W., Melchionda N., Mezzani B., Migliaccio P., Muratori F., Nizzoli U., Ostuzzi R., Panzolato G., Pasanisi F., Persichetti P., Petroni M. L., Pontieri V., Prosperi E., Renna C., Rovera G., Santini F., Saraceni V., Savina C., Scuderi N., Silecchia G., Strollo F., Todisco P., Tubili C., Ugolini G., Zamboni M., Obesity and eating disorders. Indications for the different levels of care. An Italian expert consensus document. Eating and Weight Disorders 2010 15 1-2 1 31 2-s2.0-79952108966
4. Donini L. M., Brunani A., Sirtori A., Assessing disability in morbidly obese individuals: the Italian society of obesity test for obesity-related disabilities. Disability and Rehabilitation 2011 33 25-26 2509 2518 10.3109/09638288.2011.575529
5. Kassi E., Pervanidou P., Kaltsas G., Chrousos G., Metabolic syndrome: definitions and controversies. BMC Medicine 2011 9 article 48 2-s2.0-79955562491 10.1186/1741-7015-9-48
6. Lubrano C., Saponara M., Barbaro G., Relationships between body fat distribution, epicardial fat and obstructive sleep apnea in obese patients with and without metabolic syndrome. PLoS ONE 7 2012 10 e47059 10.1371/journal.pone. 0047059
7. DeMaria E. J., Bariatric surgery for morbid obesity. The New England Journal of Medicine 2007 356 21 2176 2183 2-s2.0-34249657825 10.1056/NEJMct067019 (Pubitemid 47010843)
8. Lubrano C., Cornoldi A., Pili M., Falcone S., Brandetti F., Fabbrini E., Ginanni-Corradini S., Eramo A., Marini M., Migliaccio S., Giancotti V., Badiali M., Falsetto N., Prossomariti G., Spera G., Reduction of risk factors for cardiovascular diseases in morbid-obese patients following biliary-intestinal bypass: 3 years' follow-up. International Journal of Obesity 2004 28 12 1600 1606 2-s2.0-9444249279 10.1038/sj.ijo.0802782 (Pubitemid 39564340)
9. Lubrano C., Mariani S., Badiali M., Cuzzolaro M., Barbaro G., Migliaccio S., Genovesi G., Rossi F., Celanetti M., Fiore D., Pandolfo M. M., Specchia P., Spera G., Metabolic or bariatric surgery long-term effects of malabsorptive versus restrictive bariatric techniques on body composition and cardiometabolic risk factors. International Journal of Obesity 2010 34 9 1404 1414 2-s2.0-77956688211 10.1038/ijo.2010.54
10. Bondia-Pons I., Ryan L., Martinez J. A., Oxidative stress and inflammation interactions in human obesity. Journal of Physiology and Biochemistry 2012 68 4 701 711 10.1007/s13105-012-0154-2
11. Rossi F., Bertone C., Montanile F., Miglietta F., Lubrano C., Gandini L., Santiemma V., HDL cholesterol is a strong determinant of endothelial progenitor cells in hypercholesterolemic subjects. Microvascular Research 2010 80 2 274 279 2-s2.0-77955419461 10.1016/j.mvr.2010.05.003
12. Thayer K. A., Heindel J. J., Bucher J. R., Gallo M. A., Role of environmental chemicals in diabetes and obesity: a national toxicology program workshop review. Environmental Health Perspectives 2012 120 6 779 789 10.1289/ehp.1104597
13. Salvatori L., Caporuscio F., De Girolamo L., Morphological and functional features of human omental and subcutaneous adipose-derived stem cells isolated from obese patients. Endocrine Reviews, Supplement 1 2010 31 3 S1351 P2-468
14. Baillie-Hamilton P. F., Chemical toxins: a hypothesis to explain the global obesity epidemic. Journal of Alternative and Complementary Medicine 2002 8 2 185 192 2-s2.0-0036224930 (Pubitemid 34438491)
15. Colborn T., vom Saal F. S., Soto A. M., Developmental effects of endocrine-disrupting chemicals in wildlife and humans. Environmental Health Perspectives 1993 101 5 378 384 2-s2.0-0027428381 (Pubitemid 23343683)
16. Marini H., Minutoli L., Polito F., Bitto A., Altavilla D., Atteritano M., Gaudio A., Mazzaferro S., Frisina A., Frisina N., Lubrano C., Bonaiuto M., D'Anna R., Cannata M. L., Corrado F., Adamo E. B., Wilson S., Squadrito F., Effects of the phytoestrogen genistein on bone metabolism in osteopenic postmenopausal women: a randomized trial. Annals of Internal Medicine 2007 146 12 839 847 2-s2.0-34347383831 (Pubitemid 351650484)
17. Atteritano M., Marini H., Minutoli L., Polito F., Bitto A., Altavilla D., Mazzaferro S., D'Anna R., Cannata M. L., Gaudio A., Frisina A., Frisina N., Corrado F., Cancellieri F., Lubrano C., Bonaiuto M., Adamo E. B., Squadrito F., Effects of the phytoestrogen genistein on some predictors of cardiovascular risk in osteopenic, postmenopausal women: a two-year randomized, double-blind, placebo-controlled study. Journal of Clinical Endocrinology and Metabolism 2007 92 8 3068 3075 2-s2.0-34547742675 10.1210/jc.2006-2295 (Pubitemid 47236372)
18. Marini H., Bitto A., Altavilla D., Breast safety and efficacy of genistein aglycone for postmenopausal bone loss: a follow-up study. Journal of Clinical Endocrinology and Metabolism 2008 93 12 4787 4796 10.1210/jc.2008-1087
19. Marini H., Minutoli L., Polito F., Bitto A., Altavilla D., Atteritano M., Gaudio A., Mazzaferro S., Frisina A., Frisina N., Lubrano C., Bonaiuto M., D'Anna R., Cannata M. L., Corrado F., Cancellieri F., Faraci M., Marini R., Adamo E. B., Wilson S., Squadrito F., OPG and sRANKL serum concentrations in osteopenic, postmenopausal women after 2-year genistein administration. Journal of Bone and Mineral Research 2008 23 5 715 720 2-s2.0-42449085790 10.1359/jbmr.080201 (Pubitemid 351575025)
20. Marini H., Bitto A., Altavilla D., Efficacy of genistein aglycone on some cardiovascular risk factors and homocysteine levels: a follow-up study. Nutrition, Metabolism and Cardiovascular Diseases 2010 20 5 332 340 10.1016/j.numecd.2009.04.012
21. Castelli M., Rossi B., Corsetti F., Caroli S., Ferreri C., Cadmium and Pb in blood of Italian subjects: preliminary report of current trends. 11. Italian-Hungarian Symposium on Spectrochemistry. New Challenges in Human Health Protection: Anthropic and Remote Areas. Venice (Italy). October 19-24, 2003. Abstract Book 2003 Rome, Italy Istituto Superiore di Sanità (ISTISAN Congressi 03/C3) 142
22. Tchounwou P. B., Yedjou C. G., Patlolla A. K., Sutton D. J., Heavy metal toxicity and the environment. Molecular, Clinical and Environmental Toxicology Experientia Supplementum 2012 101 133 164 10.1007/978-3-7643-8340-4-6
23. Brama M., Gnessi L., Basciani S., Cerulli N., Politi L., Spera G., Mariani S., Cherubini S., d'Abusco A. S., Scandurra R., Migliaccio S., Cadmium induces mitogenic signaling in breast cancer cell by an ER α -dependent mechanism. Molecular and Cellular Endocrinology 2007 264 1-2 102 108 2-s2.0-33846301034 10.1016/j.mce.2006.10.013 (Pubitemid 46110939)
24. 2004, http://ec.europa.eu/food/food/chemicalsafety/contaminants/scoop-3- 2-11-heavy-metals-report-en.pdf
25. Castelli M., Rossi B., Corsetti F., Mantovani A., Spera G., Lubrano C., Silvestroni L., Patriarca M., Chiodo F., Menditto A., Levels of cadmium and lead in blood: an application of validated methods in a group of patients with endocrine/metabolic disorders from the Rome area. Microchemical Journal 2005 79 1-2 349 355 2-s2.0-19944433046 10.1016/j.microc.2004.05.003 (Pubitemid 40136516)
26. Wren C. D., Cause-effect linkages between chemicals and populations of mink (Mustela vision) and otter (Lutra canadensis) in the Great Lakes basin. Journal of Toxicology and Environmental Health 1991 33 4 549 585 2-s2.0-0025868276
27. Hansen P. D., von Westernhagen H., Rosenthal H., Chlorinated hydrocarbons and hatching success in Baltic herring spring spawners. Marine Environmental Research 1985 15 1 59 76 2-s2.0-0021890666 10.1016/0141-1136(85)90038-8
28. Leatherland J. F., Colborn T., Clement C., Endocrine and reproductive function in Great Lakes salmon. Chemically Induced Alterations in Sexual and Functional Development: The Human-Wildlife Connection 1992 Princeton, NJ, USA Princeton Scientific Publishing 129 146
29. Pesatori A. C., Consonni D., Tironi A., Zocchetti C., Fini A., Bertazzi P. A., Cancer in a young population in a dioxin-contaminated area. International Journal of Epidemiology 1993 22 6 1010 1013 2-s2.0-0027744421 (Pubitemid 24025677)
30. Calafat A. M., Needham L. L., Gore A. C., Human exposures and body burdens of endocrine-disrupting chemicals. Endocrine-Disrupting Chemicals: From Basic Research to Clinical Practice 2007 Totowa, NJ, USA Humana Press 253 268
31. Casals-Casas C., Feige J. N., Desvergne B., Interference of pollutants with PPARs: endocrine disruption meets metabolism. International Journal of Obesity 2008 32 supplement 6 S53 S61 2-s2.0-57749098636 10.1038/ijo.2008.207
32. Sheehan D. M., Willingham E., Gaylor D., Bergeron J. M., Crews D., No threshold dose for estradiol-induced sex reversal of turtle embryos: how little is too much? Environmental Health Perspectives 1999 107 2 155 159 2-s2.0-0032987028 (Pubitemid 29137728)
33. vom Saal F. S., Akingbemi B. T., Belcher S. M., Birnbaum L. S., Crain D. A., Eriksen M., Farabollini F., Guillette L. J., Hauser R., Heindel J. J., Ho S. M., Hunt P. A., Iguchi T., Jobling S., Kanno J., Keri R. A., Knudsen K. E., Laufer H., LeBlanc G. A., Marcus M., McLachlan J. A., Myers J. P., Nadal A., Newbold R. R., Olea N., Prins G. S., Richter C. A., Rubin B. S., Sonnenschein C., Soto A. M., Talsness C. E., Vandenbergh J. G., Vandenberg L. N., Walser-Kuntz D. R., Watson C. S., Welshons W. V., Wetherill Y., Zoeller R. T., Chapel Hill bisphenol A expert panel consensus statement: integration of mechanisms, effects in animals and potential to impact human health at current levels of exposure. Reproductive Toxicology 2007 24 2 131 138 2-s2.0-34548528825 10.1016/j.reprotox.2007.07.005 (Pubitemid 47385099)
34. Barker D. J. P., The developmental origins of adult disease. European Journal of Epidemiology 2003 18 733 736 (Pubitemid 37039967)
35. Skinner M. K., Manikkam M., Guerrero-Bosagna C., Epigenetic transgenerational actions of environmental factors in disease etiology. Trends in Endocrinology and Metabolism 2010 21 4 214 222 2-s2.0-77950625195 10.1016/j.tem.2009.12.007
36. Hanson M. A., Gluckman P. D., Developmental origins of health and disease: new insights. Basic and Clinical Pharmacology and Toxicology 2008 102 2 90 93 10.1111/j.1742-7843.2007.00186.x (Pubitemid 351143434)
37. Morgan D. K., Whitelaw E., The role of epigenetics in mediating environmental effects on phenotype. Nestle Nutrition Workshop Series: Pediatric Program 2009 63 109 119 2-s2.0-66149091609 10.1159/000209976
38. Petrangeli E., Lubrano C., Ravenna L., Vacca A., Cardillo M. R., Salvatori L., Sciarra F., Frati L., Gulino A., Gene methylation of oestrogen and epidermal growth factor receptors in neoplastic and perineoplastic breast tissues. The British Journal of Cancer 1995 72 4 973 975 2-s2.0-0028817794
39. Petrangeli E., Lubrano C., Ortolani F., Ravenna L., Vacca A., Sciacchitano S., Frati L., Gulino A., Estrogen receptors: new perspectives in breast cancer management. Journal of Steroid Biochemistry and Molecular Biology 1994 49 4-6 327 331 2-s2.0-0027983828 10.1016/0960-0760(94)90275-5 (Pubitemid 24240618)
40. Diamanti-Kandarakis E., Bourguignon J. P., Giudice L. C., Hauser R., Prins G. S., Soto A. M., Zoeller R. T., Gore A. C., Endocrine-disrupting chemicals: an endocrine society scientific statement. Endocrine Reviews 2009 30 4 293 342 2-s2.0-67449132400 10.1210/er.2009-0002
41. Chen J. Q., Brown T. R., Russo J., Regulation of energy metabolism pathways by estrogens and estrogenic chemicals and potential implications in obesity associated with increased exposure to endocrine disruptors. Biochimica et Biophysica Acta 2009 1793 7 1128 1143 2-s2.0-67649398814 10.1016/j.bbamcr. 2009.03.009
42. Brown L. M., Gent L., Davis K., Clegg D. J., Metabolic impact of sex hormones on obesity. Brain Research 2010 1350 77 85 2-s2.0-77956176609 10.1016/j.brainres.2010.04.056
43. Cooke P. S., Naaz A., Role of estrogens in adipocyte development and function. Experimental Biology and Medicine 2004 229 11 1127 1135 (Pubitemid 39602255)
44. Heine P. A., Taylor J. A., Iwamoto G. A., Lubahn D. B., Cooke P. S., Increased adipose tissue in male and female estrogen receptor- α knockout mice. Proceedings of the National Academy of Sciences of the United States of America 2000 97 23 12729 12734 10.1073/pnas.97.23.12729
45. Newbold R. R., Prenatal exposure to diethylstilbestrol (DES). Fertility and Sterility 2008 89 2 e55 e56 2-s2.0-41749116162 10.1016/j.fertnstert.2008.01. 062 (Pubitemid 351756456)
46. Schecter A., Malik N., Haffner D., Smith S., Harris T. R., Paepke O., Birnbaum L., Bisphenol A (BPA) in U.S. food. Environmental Science and Technology 2010 44 24 9425 9430 2-s2.0-78650287986 10.1021/es102785d
47. Alonso-Magdalena P., Ropero A. B., Carrera M. P., Cederroth C. R., Baquié M., Gauthier B. R., Nef S., Stefani E., Nadal A., Pancreatic insulin content regulation by the Estrogen receptor ER α PLoS ONE 2008 3 4 2-s2.0-44349121098 10.1371/journal.pone.0002069 e2069 (Pubitemid 352025028)
48. Miyawaki J., Sakayama K., Kato H., Yamamoto H., Masuno H., Perinatal and postnatal exposure to bisphenol A increase adipose tissue mass and serum cholesterol level in mice. Journal of Atherosclerosis and Thrombosis 2007 14 5 245 252 2-s2.0-38449087228
49. Heindel J. J., vom Saal F. S., Role of nutrition and environmental endocrine disrupting chemicals during the perinatal period on the aetiology of obesity. Molecular and Cellular Endocrinology 2009 304 1-2 90 96 2-s2.0-67349125425 10.1016/j.mce.2009.02.025
50. Sakurai K., Kawazuma M., Adachi T., Harigaya T., Saito Y., Hashimoto N., Mori C., Bisphenol A affects glucose transport in mouse 3T3-F442A adipocytes. The British Journal of Pharmacology 2004 141 2 209 214 2-s2.0-1342280381 10.1038/sj.bjp.0705520 (Pubitemid 38250890)
51. vom Saal F. S., Nagel S. C., Coe B. L., Angle B. M., Taylor J. A., The estrogenic endocrine disrupting chemical bisphenol A, (BPA) and obesity. Molecular and Cellular Endocrinology 2012 354 1-2 74 84 10.1016/j.mce.2012.01. 001
52. Wilson N. K., Chuang J. C., Morgan M. K., Lordo R. A., Sheldon L. S., An observational study of the potential exposures of preschool children to pentachlorophenol, bisphenol-A, and nonylphenol at home and daycare. Environmental Research 2007 103 1 9 20 2-s2.0-33845409594 10.1016/j.envres.2006. 04.006 (Pubitemid 44894404)
53. Carwile J. L., Michels K. B., Urinary bisphenol A and obesity: NHANES 2003-2006. Environmental Research 2011 111 6 825 830 2-s2.0-79960639578 10.1016/j.envres.2011.05.014
54. Lang I. A., Galloway T. S., Scarlett A., Henley W. E., Depledge M., Wallace R. B., Melzer D., Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults. The Journal of the American Medical Association 2008 300 11 1303 1310 2-s2.0-51949106158 10.1001/jama.300.11.1303
55. Melzer D., Osborne N. J., Henley W. E., Urinary bisphenol A concentration and risk of future coronary artery disease in apparently healthy men and women. Circulation 2012 125 12 1482 1490 10.1161/CIRCULATIONAHA.111.069153
56. Zoeller R. T., Bansal R., Parris C., Bisphenol-A, an environmental contaminant that acts as a thyroid hormone receptor antagonist in vitro, increases serum thyroxine, and alters RC3/neurogranin expression in the developing rat brain. Endocrinology 2005 146 2 607 612 2-s2.0-12344333360 10.1210/en.2004-1018 (Pubitemid 40129816)
57. Legler J., New insights into the endocrine disrupting effects of brominated flame retardants. Chemosphere 2008 73 2 216 222 2-s2.0-50049088774 10.1016/j.chemosphere.2008.04.081
58. Sargis R. M., Johnson D. N., Choudhury R. A., Brady M. J., Environmental endocrine disruptors promote adipogenesis in the 3T3-L1 cell line through glucocorticoid receptor activation. Obesity 2010 18 7 1283 1288 2-s2.0-77954104861 10.1038/oby.2009.419
59. Nakamura K., Moore R., Negishi M., Sueyoshi T., Nuclear pregnane X receptor cross-talk with FoxA2 to mediate drug-induced regulation of lipid metabolism in fasting mouse liver. The Journal of Biological Chemistry 2007 282 13 9768 9776 2-s2.0-34248202757 10.1074/jbc.M610072200 (Pubitemid 47104600)
60. Gao J., He J., Zhai Y., Wada T., Xie W., The constitutive androstane receptor is an antiobesity nuclear receptor that improves insulin sensitivity. The Journal of Biological Chemistry 2009 284 38 25984 25992 10.1074/jbc.M109. 016808
61. Moreau A., Vilarem M. J., Maurel P., Pascussi J. M., Xenoreceptors CAR and PXR activation and consequences on lipid metabolism, glucose homeostasis, and inflammatory response. Molecular Pharmaceutics 2008 5 1 35 41 2-s2.0-39749171761 10.1021/mp700103m (Pubitemid 351300032)
62. Ren H., Aleksunes L. M., Wood C., Vallanat B., George M. H., Klaassen C. D., Corton J. C., Characterization of peroxisome proliferator-activated receptor α -independent effects of PPAR α activators in the rodent liver: di-(2-ethylhexyl) phthalate also activates the constitutive-activated receptor. Toxicological Sciences 2009 113 1 45 59 2-s2.0-75249083175 10.1093/toxsci/kfp251 kfp251
63. Bock K. W., Köhle C., Ah receptor: dioxin-mediated toxic responses as hints to deregulated physiologic functions. Biochemical Pharmacology 2006 72 4 393 404 2-s2.0-33745965633 10.1016/j.bcp.2006.01.017 (Pubitemid 44061741)
64. Cimafranca M. A., Hanlon P. R., Jefcoate C. R., TCDD administration after the pro-adipogenic differentiation stimulus inhibits PPAR γ through a MEK-dependent process but less effectively suppresses adipogenesis. Toxicology and Applied Pharmacology 2004 196 1 156 168 2-s2.0-1642333554 10.1016/j.taap.2003.12.005 (Pubitemid 38393703)
65. http://www.who.int/ipcs/publications/en/ch3.pdf
66. Silvestroni L., Rossi F., Magnanti M., Lubrano C., Santiemma V., Palleschi S., A novel aspect of lindane testicular toxicity: in vitro effects on peritubular myoid cells. Reproductive Toxicology 1999 13 6 431 441 2-s2.0-0033226725 10.1016/S0890-6238(99)00040-4 (Pubitemid 30017320)
67. Heng K., Anand-Ivell R., Teerds K., Ivell R., The endocrine disruptors dibutyl phthalate (DBP) and diethylstilbestrol (DES) influence Leydig cell regeneration following ethane dimethane sulphonate treatment of adult male rats. International Journal of Andrology 2012 35 3 353 363 10.1111/j.1365-2605.2011. 01231.x
68. Silvestroni L., Rossi F., Magnanti M., Lubrano C., Santiemma V., Palleschi S., A novel aspect of lindane testicular toxicity: in vitro effects on peritubular myoid cells. Reproductive Toxicology 1999 13 6 431 441 2-s2.0-0033226725 10.1016/S0890-6238(99)00040-4 (Pubitemid 30017320)
69. Basciani S., Brama M., Mariani S., de Luca G., Arizzi M., Vesci L., Pisano C., Dolci S., Spera G., Gnessi L., Imatinib mesylate inhibits Leydig cell tumor growth: evidence for in vitro and in vivo activity. Cancer Research 2005 65 5 1897 1903 2-s2.0-20144387154 10.1158/0008-5472.CAN-04-2181 (Pubitemid 40478618)
70. Basciani S., Mariani S., Spera G., Gnessi L., Role of platelet-derived growth factors in the testis. Endocrine Reviews 2010 31 6 916 939 10.1210/er.2010-0004
71. Mariani S., Basciani S., Arizzi M., Spera G., Gnessi L., PDGF and the testis. Trends in Endocrinology and Metabolism 2002 13 1 11 17 2-s2.0-0036134353 10.1016/S1043-2760(01)00518-5 (Pubitemid 36734010)
72. Lubrano C., Sciarra F., Spera G., Petrangeli E., Toscano V., Rombola N., Palleschi F., Palma E., Di Silverio F., Immunoreactive EGF in human benign prostatic hyperplasia: relationships with androgen and estrogen receptors. Journal of Steroid Biochemistry and Molecular Biology 1992 41 3-8 683 687 2-s2.0-0026511703
73. Petrangeli E., Sciarra F., Di Silverio F., Toscano V., Lubrano C., Conti C., Concolino G., Effects of two different medical treatments on dihydrotestosterone content and androgen receptors in human benign prostatic hyperplasia. Journal of Steroid Biochemistry 1988 30 1-6 395 399 2-s2.0-0023762685
74. Lubrano C., Toscano V., Petrangeli E., Spera G., Trlotta M. C., Rombola N., Frati L., Di Silverio F., Sciarra F., Relationship between epidermal growth factor and its receptor in human benign prostatic hyperplasia. Journal of Steroid Biochemistry and Molecular Biology 1993 46 4 463 468 10.1016/0960-0760(93)90100-B (Pubitemid 23312317)
75. Wu J. H., Jiang X. R., Liu G. M., Liu X. Y., He G. L., Sun Z. Y., Oral exposure to low-dose bisphenol A aggravates testosterone-induced benign hyperplasia prostate in rats. Toxicology and Industrial Health 2011 27 9 810 819 10.1177/0748233711399310
76. Margel D., Fleshner N. E., Oral contraceptive use is associated with prostate cancer: an ecological study. The British Medical Journal 2011 1 2 e000311 10.1136/bmjopen-2011-000311
77. Ravenna L., Salvatori L., Morrone S., Lubrano C., Cardillo M. R., Sciarra F., Frati L., Di Silverio F., Petrangeli E., Effects of triptorelin, a gonadotropin-releasing hormone agonist, on the human prostatic cell lines PC3 and LNCaP. Journal of Andrology 2000 21 4 549 557 2-s2.0-0033918911 (Pubitemid 30437701)
78. Ravenna L., Lubrano C., Di Silverio F., Vacca A., Felli M. P., Maroder M., D'Eramo G., Sciarra F., Frati L., Gulino A., Petrangeli E., Androgenic and antiandrogenic control on epidermal growth factor, epidermal growth factor receptor, and androgen receptor expression in human prostate cancer cell line LNCaP. Prostate 1995 26 6 290 298 2-s2.0-0028998283 10.1002/pros.2990260604
79. Kim K., Lee H., Choi K., Bisphenol A and phthalate stimulated the growth of human prostate cancer cells and altered downstream target genes of ras signaling pathway. Endocrine Abstracts 2012 29 article P751
80. Trimboli P., Ulisse S., Graziano F. M., Marzullo A., Ruggieri M., Calvanese A., Piccirilli F., Cavaliere R., Fumarola A., D'Armiento M., Trend in thyroid carcinoma size, age at diagnosis, and histology in a retrospective study of 500 cases diagnosed over 20 years. Thyroid 2006 16 11 1151 1155 2-s2.0-33845241503 10.1089/thy.2006.16.1151 (Pubitemid 44864490)
81. Golden S. H., Brown A., Cauley J. A., Chin M. H., Gary-Webb T. L., Kim C., Sosa J. A., Sumner A. E., Anton B., Health disparities in endocrine disorders: biological, clinical, and nonclinical factors-an endocrine society statement. Journal of Clinical Endocrinology and Metabolism 2012 97 9 E1579 E1639 10.1210/jc.2012-2043
82. Lee M. L., Chen G. G., Vlantis A. C., Tse G. M. K., Leung B. C. H., Van Hasselt C. A., Induction of thyroid papillary carcinoma cell proliferation by estrogen is associated with an altered expression of Bcl-xL. Cancer Journal 2005 11 2 113 121 2-s2.0-23944435017 10.1097/00130404-200503000-00006 (Pubitemid 44698822)
83. Grün F., Blumberg B., Environmental obesogens: organotins and endocrine disruption via nuclear receptor signaling. Endocrinology 2006 147 6 S50 S55 2-s2.0-33646812194 10.1210/en.2005-1129 (Pubitemid 43764590)
84. Turrio Baldassarri L., La Rocca C., Iacovella N., Determination of polycyclic aromatic hydrocarbons and polychlorobiphenyls in whole human blood by SFE-GC-MS. Organohalogen Compounds 1999 40 285 288
85. Lubrano C., Obesità e inquinamento. Sicurezza Sanitaria 2008 98 38 45
86. Lubrano C., Bottaccioli F., Interferenti endocrini e obesità Geni e comportamenti. Scienza e arte della vita 2009 Milan, Italy Red Edizioni 219 226
87. EC, Towards the establishment of a priority list of substances for further evaluation of their role in endocrine disruption-preparation of a candidate list of substances as a basis for priority setting. Final Report by BKH Consulting Engineers, Delft, The Netherlands TNO Nutrition and Food Research, Zeist, The Netherlands, for the European Commission, EC DG ENV M0355008/1786Q/10/11/00, 2000
88. Turrio-Baldassarri L., La Rocca C., Iacovella N., Determination of polycyclic aromatic hydrocarbons and polychlorobiphenyls in whole human blood by SFE EGC-MS. Organohalogen Compounds 1999 40 285 288
89. Hatch E. E., Nelson J. W., Stahlhut R. W., Webster T. F., Association of endocrine disruptors and obesity: perspectives from epidemiological studies. International Journal of Andrology 2010 33 2 324 332 2-s2.0-77949629830 10.1111/j.1365-2605.2009.01035.x
90. http://www.who.int/ipcs/publications/en/ch3.pdf
91. Karmaus W., Osuch J. R., Eneli I., Mudd L. M., Zhang J., Mikucki D., Haan P., Davis S., Maternal levels of dichlorodiphenyl-dichloroethylene (DDE) may increase weight and body mass index in adult female offspring. Occupational and Environmental Medicine 2009 66 3 143 149 2-s2.0-61849107135 10.1136/oem.2008. 041921
92. Smink A., Ribas-Fito N., Garcia R., Torrent M., Mendez M. A., Grimalt J. O., Sunyer J., Exposure to hexachlorobenzene during pregnancy increases the risk of overweight in children aged 6 years. Acta Paediatrica, International Journal of Paediatrics 2008 97 10 1465 1469 2-s2.0-51349110146 10.1111/j.1651-2227. 2008.00937.x
93. Casals-Casas C., Desvergne B., Endocrine disruptors: from endocrine to metabolic disruption. Annual Review of Physiology 2011 73 135 162 2-s2.0-79951805682 10.1146/annurev-physiol-012110-142200
94. Elobeid M. A., Padilla M. A., Brock D. W., Ruden D. M., Allison D. B., Endocrine disruptors and obesity: an examination of selected persistent organic pollutants in the NHANES 1999-2002 data. International Journal of Environmental Research and Public Health 2010 7 7 2988 3005 2-s2.0-78649611653 10.3390/ijerph7072988
95. Fierens S., Mairesse H., Heilier J. F., de Burbure C., Focant J. F., Eppe G., de Pauw E., Bernard A., Dioxin/polychlorinated biphenyl body burden, diabetes and endometriosis: findings in a population-based study in Belgium. Biomarkers 2003 8 6 529 534 2-s2.0-1842484141 10.1080/1354750032000158420 (Pubitemid 38418283)
96. Sato S., Shirakawa H., Tomita S., Ohsaki Y., Haketa K., Tooi O., Santo N., Tohkin M., Furukawa Y., Gonzalez F. J., Komai M., Low-dose dioxins alter gene expression related to cholesterol biosynthesis, lipogenesis, and glucose metabolism through the aryl hydrocarbon receptor-mediated pathway in mouse liver. Toxicology and Applied Pharmacology 2008 229 1 10 19 2-s2.0-42749087554 10.1016/j.taap.2007.12.029
97. Matthews J., Gustafsson J. A., Estrogen receptor and aryl hydrocarbon receptor signaling pathways. Nuclear Receptor Signaling 2006 4 article e016 10.1621/nrs.04016
98. Auwerx J., PPAR γ the ultimate thrifty gene. Diabetologia 1999 42 9 1033 1049 2-s2.0-0032588487 10.1007/s001250051268 (Pubitemid 29408799)
99. Feige J. N., Gelman L., Rossi D., Activation of PPAR α and PPAR γ by environmental phthalate monoesters. Toxicological Sciences 2007 74 297 308
100. Zoete V., Grosdidier A., Michielin O., Peroxisome proliferator-activated receptor structures: ligand specificity, molecular switch and interactions with regulators. Biochimica et Biophysica Acta 2007 1771 8 915 925 2-s2.0-34547661571 10.1016/j.bbalip.2007.01.007 (Pubitemid 47208545)
101. Kanayama T., Kobayashi N., Mamiya S., Nakanishi T., Nishikawa J. I., Organotin compounds promote adipocyte differentiation as agonists of the peroxisome proliferator-activated receptor γ /retinoid X receptor pathway. Molecular Pharmacology 2005 67 3 766 774 2-s2.0-14944349712 10.1124/mol.104.008409 (Pubitemid 40365324)
102. Grun F., Watanabe H., Zamanian Z., Endocrine-disrupting organotin compounds are potent inducers of adipogenesis in vertebrates. Molecular Endocrinology 2005 20 9 2141 2155 (Pubitemid 44286710)
103. http://ec.europa.eu/research/endocrine/projects-ongoing-en.html
104. Nunn A. V. W., Bell J. D., Guy G. W., Lifestyle-induced metabolic inflexibility and accelerated ageing syndrome: insulin resistance, friend or foe? Nutrition and Metabolism 2009 6 article 16 2-s2.0-65549096847 10.1186/1743-7075-6-16
105. Hotamisligil G. S., Inflammation and metabolic disorders. Nature 2006 444 7121 860 867 2-s2.0-33845866857 10.1038/nature05485 (Pubitemid 46024993)
106. Lowell B. B., Shulman G. I., Mitochondrial dysfunction and type 2 diabetes. Science 2005 307 5708 384 387 2-s2.0-12344305124 10.1126/science. 1104343 (Pubitemid 40139974)
107. Rogge M. M., The role of impaired mitochondrial lipid oxidation in obesity. Biological Research For Nursing 2009 10 4 356 373 10.1177/ 1099800408329408
108. Meigs J. B., Larson M. G., Fox C. S., Keaney J. F., Vasan R. S., Benjamin E. J., Association of oxidative stress, insulin resistance, and diabetes risk phenotypes: the framingham offspring study. Diabetes Care 2007 30 10 2529 2535 2-s2.0-35148897217 10.2337/dc07-0817 (Pubitemid 47547788)
109. Krzystek-Korpacka M., Patryn E., Boehm D., Berdowska I., Zielinski B., Noczynska A., Advanced oxidation protein products (AOPPs) in juvenile overweight and obesity prior to and following weight reduction. Clinical Biochemistry 2008 41 12 943 949 2-s2.0-47049109285 10.1016/j.clinbiochem.2008.04.024
110. Lim S., Cho Y. M., Park K. S., Lee H. K., Persistent organic pollutants, mitochondrial dysfunction, and metabolic syndrome. Annals of the New York Academy of Sciences 2010 1201 166 176 2-s2.0-77955290804 10.1111/j.1749-6632. 2010.05622.x
111. Wu M., Xu H., Shen Y., Qiu W., Yang M., Oxidative stress in zebrafish embryos induced by short-term exposure to bisphenol A, nonylphenol, and their mixture. Environmental Toxicology and Chemistry 2011 30 10 2335 2341 10.1002/etc.634
112. Yang Yj, Hong Y. C., Oh S. Y., Park M. S., Kim H., Leem J. H., Ha E. H., Bisphenol A exposure is associated with oxidative stress and inflammation in postmenopausal women. Environmental Research 2009 109 6 797 801 10.1016/j.envres.2009.04.014
113. Huggett R. J., Stegeman J. J., Page D. S., Parker K. R., Woodin B., Brown J. S., Biomarkers in fish from Prince William Sound and the Gulf of Alaska: 1999-2000. Environmental Science and Technology 2003 37 18 4043 4051 2-s2.0-0043192458 10.1021/es0342401 (Pubitemid 37108287)
114. Silins I., Högberg J., Combined toxic exposures and human health: biomarkers of exposure and effect. International Journal of Environmental Research and Public Health 2011 8 3 629 647 10.3390/ijerph8030629
115. Valavanidis A., Vlahogianni T., Dassenakis M., Scoullos M., Molecular biomarkers of oxidative stress in aquatic organisms in relation to toxic environmental pollutants. Ecotoxicology and Environmental Safety 2006 64 2 178 189 2-s2.0-33646791891 10.1016/j.ecoenv.2005.03.013 (Pubitemid 43766114)
116. Farahat F. M., Ellison C. A., Bonner M. R., Mcgarrigle B. P., Crane A. L., Fenske R. A., Lasarev M. R., Rohlman D. S., Anger W. K., Lein P. J., Olson J. R., Biomarkers of chlorpyrifos exposure and effect in Egyptian cotton field workers. Environmental Health Perspectives 2011 119 6 801 806 2-s2.0-79956204419 10.1289/ehp.1002873
117. Albers J. W., Garabrant D. H., Berent S., Richardson R. J., Paraoxonase status and plasma butyrylcholinesterase activity in chlorpyrifos manufacturing workers. Journal of Exposure Science and Environmental Epidemiology 2010 20 1 79 89 2-s2.0-73649131634 10.1038/jes.2009.9
118. Panemangalore M., Dowla H. A., Byers M. E., Occupational exposure to agricultural chemicals: effect on the activities of some enzymes in the blood of farm workers. International Archives of Occupational and Environmental Health 1999 72 2 84 88 2-s2.0-0032973913 10.1007/s004200050342 (Pubitemid 29123586)
119. Livingstone D. R., Contaminant-stimulated reactive oxygen species production and oxidative damage in aquatic organisms. Marine Pollution Bulletin 2001 42 8 656 666 2-s2.0-0034893348 10.1016/S0025-326X(01)00060-1 (Pubitemid 32717602)
120. García-Closas M., Malats N., Silverman D., Dosemeci M., Kogevinas M., Hein D. W., Tardón A., Serra C., Carrato A., García-Closas R.,
121. Abhishek S., Kaur N., Kaur S., Lata M., Sharma J. K., Sharma A., Association of GSTM1 and GSTT1 gene deletions with susceptibility to DNA damage in the pesticide-exposed workers of Punjab. Rejuvenation Research 2010 13 2-3 281 284 2-s2.0-77952399800 10.1089/rej.2009.0931
122. de Luca C., Scordo M. G., Cesareo E., Pastore S., Mariani S., Maiani G., Stancato A., Loreti B., Valacchi G., Lubrano C., Raskovic D., De Padova L., Genovesi G., Korkina L. G., Biological definition of multiple chemical sensitivity from redox state and cytokine profiling and not from polymorphisms of xenobiotic-metabolizing enzymes. Toxicology and Applied Pharmacology 2010 248 3 285 292 2-s2.0-77953511911 10.1016/j.taap.2010.04.017
123. Celander M. C., Cocktail effects on biomarker responses in fish. Aquatic Toxicology 2011 105 3-4, supplement 72 77 10.1016/j.aquatox.2011.06.002
124. Eveillard A., Lasserre F., de Tayrac M., Polizzi A., Claus S., Canlet C., Mselli-Lakhal L., Gotardi G., Paris A., Guillou H., Martin P. G. P., Pineau T., Identification of potential mechanisms of toxicity after di-(2-ethylhexyl)- phthalate (DEHP) adult exposure in the liver using a systems biology approach. Toxicology and Applied Pharmacology 2009 236 3 282 292 2-s2.0-63949086443 10.1016/j.taap.2009.02.008